CYTOKI PHARMA
Cytoki Pharma is a biotechnology company that specializes in developing novel medicines for diseases with a significant unmet medical need with a focus on serious diseases caused by epithelial injury. CytoKi Pharma is a pre-clinical biotechnology company with focus on serious diseases caused by epithelial injury having an unmet medical need. Cytokiโs lead program is an engineered long-acting IL-22 protein licensed from a major pharmaceutical company.A correctly functioning immune system is ess... ential for keeping us healthy in the multitude of challenges our organism encounters. Numerous medicines are based on principles that activate or deactivate key proteins in the immune system in a disease context. IL-22 is a key cytokine (a class of proteins released from immune cells) in securing the survival and repair after an injury. It is the immune systemโs โSurvive and Recoverโ signal to the tissue. Our lead program is harnessing the power of IL-22, in treatment of organ injuries, through a modified IL-22 protein engineered to have optimal pharmaceutical properties.
CYTOKI PHARMA
Social Links:
Industry:
Biotechnology Life Science
Founded:
2019-01-01
Address:
Vรฆrlรธse, Hovedstaden, Denmark
Country:
Denmark
Website Url:
http://www.cytokipharma.com
Total Employee:
1+
Status:
Active
Total Funding:
45 M USD
Technology used in webpage:
Microsoft Exchange Online Person Schema Facebook Sharer Gravatar Profiles
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Lytica Therapeutics
Lytica Therapeutics, Inc. is a biotechnology company focused on developing novel peptide therapeutics.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Seventure Partners
Seventure Partners investment in Series A - Cytoki Pharma
Lundbeckfonden Emerge
Lundbeckfonden Emerge investment in Series A - Cytoki Pharma
+ND Capital
+ND Capital investment in Series A - Cytoki Pharma
Ysios Capital
Ysios Capital investment in Series A - Cytoki Pharma
Official Site Inspections
http://www.cytokipharma.com
- Host name: acd89244c803f7181.awsglobalaccelerator.com
- IP address: 75.2.60.5
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108